Oliyai Consulting Revenue
Biotechnology Research • 
Atherton, California, United States • 11-20 Employees
Oliyai Consulting revenue & valuation
| Annual revenue | $1,026,660 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,300,000 |
| Total funding | No funding |
Key Contact at Oliyai Consulting
Reza Oliyai
President and CEO, Oliyai Consulting Corporation
Company overview
| Headquarters | Atherton, California, United States |
| NAICS | 541714 |
| Keywords | Organizational Development, Due Diligence, Manufacturing, Drug-Device Combinations, Cell Therapy, Small Molecules, IM, Biologics, IV, Ophthalmic, SC, Supply Chain Design, Peptides, BLA, NDA, Quality And Compliance, Antibody-Drug Conjugates (Adcs), Inhalation, Impd, Controls), Cmc Project Management, Mrna, Cmc (Chemistry, Pediatric Dosage Forms, Maa), Asos), Cdmo & Cro Selection And Contract Negotiations, Drug Development And Commercialization, Intrathecal), Intravitreal, Long-Acting Injectables (Lai), Oligonucleotides (Sirna, Regulatory Submissions (Ind, Routes Of Delivery (Oral |
| Founded | 2022 |
| Employees | 11-20 |
Oliyai Consulting Email Formats
Oliyai Consulting uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@gilead.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@gilead.com | 100% |
About Oliyai Consulting
Oliyai Consulting Corporation (OCC) is a premier consulting firm serving the pharmaceutical and biotech industries, distinguished by the real-world expertise of its subject matter experts. We partner with 100+ organizations from global pharma and biotech leaders to emerging startups to accelerate drug development from lead optimization through commercialization, with a core focus on Chemistry, Manufacturing, and Controls (CMC). Our 100+ seasoned professionals bring extensive and integrated experience in drug development, manufacturing, and commercialization, supported by strong connections to the global CRO/CDMO network. We deliver cost-effective, tailored solutions to complex strategic, scientific, technical, and operational challenges. Our expertise spans small molecules, peptides, biologics, ADCs, oligonucleotides (siRNA, mRNA, ASOs), cell therapies, and drug–device combination products. We support multiple delivery routes including oral, injectable (IV, IM, SC, LAI), intravitreal, inhalation, ophthalmic, intrathecal, and pediatric formulations. OCC provides phase-appropriate regulatory, quality, and compliance support and is actively involved in numerous IND, IMPD, NDA, MAA, and BLA submissions. Beyond CMC, OCC offers expertise in preclinical development, patent litigation support, and organizational development. Founded by Dr. Reza Oliyai, a pharmaceutical leader with over 30 years of industry experience, OCC is built on a legacy of innovation and operational excellence. As Senior Vice President at Gilead Sciences, Dr. Oliyai led the development of more than 200 drug candidates and the commercialization of 27 products — experience that continues to guide OCC’s mission to help clients navigate complexity and achieve success.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Oliyai Consulting has 7 employees across 4 departments.
Departments
Number of employees
Funding Data
Oliyai Consulting has never raised funding before.
Saudi Arabia
United Kingdom
MalaysiaFrequently asked questions
4.8
40,000 users
